surmount-osa tirzepatide results on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the randomized trial VisualAbstract: Tirzepatide Improved Outcomes in
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



























